Skip to content

The Oncology Institute, Inc. TOI Accrued Insurance Current And Noncurrent

Other financials

Income statement

See full
Revenue$147.4M+41.2%
Operating income-$6.5M+34.3%
Net income-$2.5M+87.3%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$30.3M-23.8%
Total debt$104.9M+2.5%
Total equity-$16.3M-421%
Total assets$168.2M+2.6%

Cash flow

See full
Operating cash flow-$2.2M+55.6%
CapEx$1.0M+218%
Free cash flow-$3.3M+38.7%

Valuation

See full
Market cap$511.91M+133%
Enterprise value$586.58M+108%
P/S0.9×+0.4×

Profitability

See full
Operating margin-6%-2.1pp
Net margin-8%-2.7pp
FCF margin-5.1%

Returns & leverage

See full
Return on equity-277.6%-700pp
Debt / equity20.2×+17.3×
Current ratio1.5×-0.3×

Where this comes from

Reported directly by The Oncology Institute, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedInsuranceCurrentAndNoncurrent.

The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Oncology Institute, Inc.'s accrued insurance current and noncurrent.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Oncology Institute, Inc.'s accrued insurance current and noncurrent?
The Oncology Institute, Inc. (TOI) reported accrued insurance current and noncurrent of $530K in Q1 2026.
How has The Oncology Institute, Inc.'s accrued insurance current and noncurrent changed year-over-year?
The Oncology Institute, Inc.'s accrued insurance current and noncurrent decreased by 2.6% year-over-year, from $544K to $530K.
What is the long-term trend for The Oncology Institute, Inc.'s accrued insurance current and noncurrent?
Over 2 years (2023 to 2025), The Oncology Institute, Inc.'s accrued insurance current and noncurrent has grown at a -11.0% compound annual growth rate (CAGR), from $1M to $794K.